using cost-effectiveness analysis to inform state policy · using cost-effectiveness analysis to...

22
“Using CEA to inform state policy” 30 November 2017 © Jeffrey S. Hoch, PhD 1 USING COST- EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare Policy and Research Professor and Chief, Division of Health Policy Management Department of Public Health Sciences, University of California, Davis Health Policy and Management E: [email protected] T: @j_hoch https://twitter.com/j_hoch 2 © Jeffrey Hoch, PhD

Upload: others

Post on 20-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 1

USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY

Jeffrey S. Hoch, PhD

Associate Director, Center for Healthcare Policy and Research

Professor and Chief, Division of Health Policy Management

Department of Public Health Sciences,

University of California, Davis

Health Policy and Management

E: [email protected]

T: @j_hoch

https://twitter.com/j_hoch

2

© Jeffrey Hoch, PhD

Page 2: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 2

Disclaimer

▪The opinions expressed in this talk are mine and are not meant to represent official positions of the people or groups with whom I work.

© Jeffrey Hoch, PhD

4

THIS SESSION IS NOT…HOW TO DO CEA

Mathy, Statsy, or Numbery

Focused on health & other areas

© Jeffrey Hoch, PhD

WHY YOU SHOULD CARE

Costs challenge

patients and

payers

01

Paying for Value(not volume) is a popular ‘solution’

02Cost-effectiveness analysis is a way to look at Value.

03

6

© Jeffrey Hoch, PhD

Page 3: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 3

WHAT IS VALUE?

“In most industries, “value” as defined by consumers is associated with in four attributes:

Accessibility: “can I get what I need or want from you?”

Service: “is dealing with you a pleasant experience?”

Effectiveness: “is what you’re providing going to satisfy my need or want?”

Costs: “what’s the cost to me and my family and is it worth it?”

https://tinyurl.com/ow7rfl7

process

outcome

cost

7

© Jeffrey Hoch, PhD

The trip and

the options

What it “costs”what you “get”

The Trade-off

8

© Jeffrey Hoch, PhD

https://tinyurl.com/y9eygdms

9

© Jeffrey Hoch, PhD

Page 4: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 4

“In collaboration with the partner organizations, Consumer Reports has created resources… to engage

in… conversations about the overuse of medical tests and procedures that provide little benefit and in

some cases harm.

“Choosing Wisely recommendations should not be used to establish coverage decisions or exclusions.

Rather, they are meant to spur conversation about what is appropriate and necessary treatment. As

each patient situation is unique, providers and patients should use the recommendations as guidelines

to determine an appropriate treatment plan together.

Policy is made for a population, not a patient.

How to use Cost-Effectiveness Analysis (CEA) to look at

Value at the population (policy) level?

10

© Jeffrey Hoch, PhD

COUNT DOWN TO USE

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

11

© Jeffrey Hoch, PhD

WHERE ARE WE?

An economic evaluation

tells you a tradeoff

located in one of 4 areas

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

12

© Jeffrey Hoch, PhD

Page 5: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 5

Less effective More effective

Costs more

Costs less

4 potential outcomes

2 dimensions

x

2 directions

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

13

© Jeffrey Hoch, PhD

2 X 2 TABLE = 4 QUESTIONS

“More or less” means > 2 options.

• Are they relevant/correct?

Whose cost?

• Decision maker’s perspective included?

Which outcome (what to use as effect)?

• Is one that matters included?

Over what time horizon?

• Over policy/clinically relevant time period?

“more than” or “less than” 1 option is

compared to a 2nd option.

Does the “usual care” in the analysis match

your context / reality?

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

14

© Jeffrey Hoch, PhD

2 X 2 TABLE = 4 QUESTIONS

“More or less” means > 2 options.

• Are they relevant/correct?

Whose cost?

• Decision maker’s perspective included?

Which outcome (what to use as effect)?

• Is one that matters included?

Over what time horizon?

• Over policy/clinically relevant time period?

The decision maker cares about the

decision maker’s costs (i.e., not paying =

not a cost)

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

15

© Jeffrey Hoch, PhD

Page 6: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 6

2 X 2 TABLE = 4 QUESTIONS

“More or less” means > 2 options.

• Are they relevant/correct?

Whose cost?

• Decision maker’s perspective included?

Which outcome (what to use as effect)?

• Is one that matters included?

Over what time horizon?

• Over policy/clinically relevant time period!

What are you trying to accomplish with

this policy or program?

What amount of “success” does the new option offer?

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

16

© Jeffrey Hoch, PhD

2 X 2 TABLE = 4 QUESTIONS

“More or less” means > 2 options.

• Are they relevant/correct?

Whose cost?

• Decision maker’s perspective included?

Which outcome (what to use as effect)?

• Is one that matters included?

Over what time horizon?

• Over policy/clinically relevant time period!

0

200

400

600

800

1000

1200

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6

Time horizon matters

Costs Benefits

cost benefit

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

17

© Jeffrey Hoch, PhD

2 X 2 TABLE = 4 QUESTIONS

“More or less” means > 2 options.

• Are they relevant/correct?

Whose cost?

• Decision maker’s perspective included?

Which outcome (what to use as effect)?

• Is one that matters included?

Over what time horizon?

• Over policy/clinically relevant time period!

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

18

© Jeffrey Hoch, PhD

Page 7: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 7

Less effect More effect

Costs more

Costs less

4 potential outcomes

RightCost?

RightEffect?

Both Cost and Effect

19

© Jeffrey Hoch, PhD

EXAMPLE OF THE MAIN TYPES OF CHALLENGES

1) Can you find the right box?

• YES or NOT yet

II) Is the information useful/relevant?

• YES or NOT yet

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

20

© Jeffrey Hoch, PhD

A NEW SMOKING CESSATION PROGRAM

A 6 month study shows that a new smoking cessation program costs $2,500 per person.

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

21

© Jeffrey Hoch, PhD

Page 8: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 8

A NEW SMOKING CESSATION PROGRAM

A 6 month study shows that a new smoking cessation program costs $2,500 per person.

Some of the benefits reported by those who quit include:

Better appearance

Better breath and whiter teeth

Appetite for food is rediscovered

An improved sense of smell

Better lung capacity

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

22

© Jeffrey Hoch, PhD

EXAMPLE COMPLETED

The new smoking cessation program helps more people quit smoking

than the standard practice and costs more over a 50 year time horizon.

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

23

© Jeffrey Hoch, PhD

COUNT DOWN TO USE

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

24

© Jeffrey Hoch, PhD

Page 9: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 9

Less effective More effective

Costs more

Costs less

4 potential outcomes

2 dimensions

x

2 directions

Easy NO

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

25

© Jeffrey Hoch, PhD

Less effective More effective

Costs more

Costs less

4 potential outcomes

2 dimensions

x

2 directions

Easy YES

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

26

© Jeffrey Hoch, PhD

Less effective More effective

Costs more

Costs less

4 potential outcomes

2 dimensions

x

2 directions

It Depends

It Depends

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

27

© Jeffrey Hoch, PhD

Page 10: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 10

Less effective Similar Effect More effective

Costs more

Similar Costs

Costs less

3 potential findings

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

28

© Jeffrey Hoch, PhD

TEST YOUR UNDERSTANDING

• What do you need to know?

https://tinyurl.com/y8avgp854 Quadrants,3 Findings, 2 Items of interest, 1 Thing

29

© Jeffrey Hoch, PhD

TEST YOUR UNDERSTANDING, CONTINUED

• What might you find?

https://tinyurl.com/y8avgp854 Quadrants,3 Findings, 2 Items of interest, 1 Thing

30

© Jeffrey Hoch, PhD

Page 11: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 11

COUNT DOWN TO USE

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

31

© Jeffrey Hoch, PhD

Less effective Same Effect More effective

Costs more

Costs the same

Costs less

2 items of interest: 1) Estimate

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

32

© Jeffrey Hoch, PhD

Less effective Same Effect More effective

Costs more

Costs the same

Costs less

2 items of interest: 2) Uncertainty

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

33

© Jeffrey Hoch, PhD

Page 12: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 12

ESTIMATE

• How much extra cost?

• How much extra effect?

• How much extra cost per extra effect?

• How much more extra benefitthan extra cost?

• What other values are possible?

• What is the 95% CI?

UNCERTAINTY

USING 2 ITEMS OF INTEREST: 1) ESTIMATE & 2) UNCERTAINTY

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

$75,000 extra cost and 6 more months of life

$75,000 / 0.5 years = $150,000 per year of life

34

© Jeffrey Hoch, PhD

Patient outcome

Cost

C

E

35

© Jeffrey S. Hoch, PhD4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing = 6 months or 0.5 year

= $75,000

$75,000 extra cost and 6 more months of life

$75,000 / 0.5 years = $150,000 per year of life

More Effective, E > 0Less Effective, E < 0

More Costly, C > 0

Less Costly, C < 0

Less Costly/Less Effective

Lose-Lose

Win-Win

More Costly/More Effective

COST-EFFECTIVENESS PLANE

© Jeffrey S. Hoch, PhD

36

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

36

Page 13: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 13

More Effective, E > 0Less Effective, E < 0

More Costly, C > 0

Less Costly, C < 0

Less Costly/Less Effective

More Costly/More Effective

COST-EFFECTIVENESS PLANE

© Jeffrey S. Hoch, PhD

37

0.5 yr 1.0 year

$75,000

$150,000

$75,000 extra cost and 6 more months of life

$75,000 / 0.5 years = $150,000 per year of life

Extra cost

Extra cost per

1 extra effect (ICER)

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

THE STORY

OF ONE

ARTICLE…

© JEFFREY S. HOCH, PHD

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

38

Estimates

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

39

© Jeffrey Hoch, PhD

Page 14: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 14

Uncertainty

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

40

© Jeffrey Hoch, PhD

WHAT IS THE DECISION MAKER WILLING TO PAY?

Is $150k per year of life worth it?

YES!This is cost-

effective!

noThis is not cost-

effective

WTP

WTF?

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

41

© Jeffrey Hoch, PhD

WTP

P(CE)

Uncertainty

42

© Jeffrey Hoch, PhD

Page 15: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 15

COUNT DOWN TO USE

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

43

© Jeffrey Hoch, PhD

In a perfect theory world (where budget determines WTP)….

Calculate all of the extra cost per extra effect (using CEA) and then purchase from lowest to highest until you run out of your budget

© Jeffrey Hoch, PhD

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

44

In a perfect theory world (where WTP determines budget)….

Use CEA results to purchase from lowest to highest until you hit the magical WTP threshold (e.g., £30,000)

© Jeffrey Hoch, PhD

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

45

Page 16: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 16

Neither the budget nor the WTP are known and no payer is “buying” everything at once. No rec committee knows…

© Jeffrey Hoch, PhD

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

46

There is something odd about the choreography of the CEA…

47

© Jeffrey Hoch, PhD4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

WHAT IS BEING CONSIDERED?

“Given the available evidence on comparative effectiveness and incremental cost-effectiveness, and considering other benefits, disadvantages, and contextual considerations, what is the long-term value for money of treatmentwith acupuncture and usual care versus usual care alone for patients with chronic low back pain?

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

48

© Jeffrey Hoch, PhD

Page 17: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 17

CHBRP

Clinical

evidence

Patient

values

Cost-effectivenessFeasibility of Adoption

(into the Health System)

The 4 key areas

50

© Jeffrey S. Hoch, PhD4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

LESSONS FROM FRONT ROW SEATS…

1) Other evidence in addition to economic evidence is used in decision

making

2) almost no one is a health

economist among policy advisors and policy makers

3) Good & Useful can be better than Perfect & Right

© Jeffrey Hoch, PhD

4 Quadrants, 3 Findings, 2 Items of interest, 1 Thing

51

Page 18: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 18

TO USE CEA, YOU MUST HAVE …

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

52 © Jeffrey Hoch, PhD

FINAL EXAM

• 1) Is this cost-effective?

• 2) How do people view CEA?

53 © Jeffrey Hoch, PhD

FINAL EXERCISE

• Example: Cost-effectiveness of epoetin-alpha (EPO) to augment

preoperative autologous blood donation (PAD) in elective surgery

• Concerns:

• Allogeneic (someone else’s) blood might have disease

• Autologous (your own) blood is costly to get, and so is EPO

“Economic analysis of erythropoietin use in orthopaedic surgery.” by Coyle D, Lee KM, Fergusson DA, Laupacis A. Transfus Med . 1999 Mar;9(1):21-30.

54 © Jeffrey Hoch, PhD

Page 19: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 19

FEEDING DATA TO A MODEL

55 © Jeffrey Hoch, PhD

COST EFFECTIVENESS RESULTS

Is EPO cost-effective? 56 © Jeffrey Hoch, PhD

COST EFFECTIVENESS RESULTSBY HOMER

Is EPO cost-effective? 57 © Jeffrey Hoch, PhD

Page 20: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 20

COST EFFECTIVENESS RESULTSBY HOMER SIMPSON

Is EPO cost-effective? What do we already know (what can we already achieve w/o EPO)?58

© Jeffrey Hoch, PhD

Intervention Life Years Extra Life Years

Cost Extra Cost

Cost per life year gained

No intervention EPO

13.037758 13.037782

0.000024

269 1857

1588

$66.3 million

PAD EPO + PAD

13.037725 13.037731

0.000006

968 2903

1935

$329.3 million

Incremental cost-effectiveness ratio (ICER) = C / E

ICER = Extra cost / Extra effect

“extra cost of 1 more unit of extra effect”

COST EFFECTIVENESS RESULTS

59 © Jeffrey Hoch, PhD

TO USE CEA, YOU MUST HAVE …

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

More costly,

more effective

Easy no

C = $1935 E= 3 minutes;

C/E = 330 mill per 1 YR

NO uncertainty shown

60 © Jeffrey Hoch, PhD

Page 21: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 21

TO USE CEA, YOU MUST HAVE …

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

61 © Jeffrey Hoch, PhD

DIFFERENT OPINIONS

SOUND L IKE…

62 © Jeffrey Hoch, PhD

WHAT HAPPENED

IN ONTARIO?

63 © Jeffrey Hoch, PhD

Page 22: Using cost-effectiveness analysis to inform state policy · USING COST-EFFECTIVENESS ANALYSIS TO INFORM STATE POLICY Jeffrey S. Hoch, PhD Associate Director, Center for Healthcare

“Using CEA to inform state policy” 30 November 2017

© Jeffrey S. Hoch, PhD 22

TO USE CEA, YOU MUST HAVE …

4 Quadrants

3 Findings

2 Items of interest

1 Thing

https://tinyurl.com/ycmqu724

64 © Jeffrey Hoch, PhD

AS HEALTHCARE BECOMES MORE EXPENSIVE…

There will be more focus on “value” (i.e., cost and effectiveness of new treatments).

Cost-effectiveness analysis (CEA) is a tool used throughout the world to help inform policy.

The questions you ask when “smart shopping” are the same ones users of CEA should ask

65 © Jeffrey Hoch, PhD

[email protected]

66© Jeffrey S. Hoch, PhD

E: [email protected]: @j_hochhttps://twitter.com/j_hoch